Matinas BioPharma Holdings, Inc.
MTNB
$0.59
-$0.05-7.84%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.46% | -14.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.46% | -14.15% | |||
| Operating Income | -1.46% | 14.15% | |||
| Income Before Tax | -24.80% | 70.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.80% | 70.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.80% | 70.79% | |||
| EBIT | -1.46% | 14.15% | |||
| EBITDA | -1.20% | 13.54% | |||
| EPS Basic | 23.06% | 61.64% | |||
| Normalized Basic EPS | -3.86% | 24.55% | |||
| EPS Diluted | 23.06% | 61.64% | |||
| Normalized Diluted EPS | -3.86% | 24.55% | |||
| Average Basic Shares Outstanding | 15.58% | 6.86% | |||
| Average Diluted Shares Outstanding | 15.58% | 6.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||